ClinicalTrials.Veeva

Menu

Probiotics as Adjunct to Nonsurgical Periodontal Treatment

U

University of Ljubljana

Status

Completed

Conditions

Periodontitis

Treatments

Other: Placebo
Dietary Supplement: Probiotic lozenges

Study type

Interventional

Funder types

Other

Identifiers

NCT04137419
2019-2-1

Details and patient eligibility

About

ProlacSan probiotic lozenges and gels contain L. plantarum and L. brevis strains with proven in vitro antimicrobial activity against P. gingivalis. In our study we aim to investigate proposed benefit of ProlacSan as adjunct to conventional initial periodontal treatment in a group (n = 40) of Grade III and IV periodontitis patients. Patients will be randomized in two groups receiving either probiotic (n = 20) or placebo (n = 20) after completion of nonsurgical treatment within 7 days. Before treatment and after three months, standard periodontal parameters will be measured by masked examiner and plaque samples harvested for cultivation of 9 most relevant periodontal pathogens. One lozenge per day of probiotic/placebo will be used during 3 months healing period. Primary outcome measures will be the number of persisting sites per patient that need additional surgical treatment defined as sites with probing depth > 4 mm and bleeding on probing.

Enrollment

40 patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • periodontitis stage III or IV
  • at least 20 teeth for evaluation
  • besides solitary crowns, no other prosthodontic tooth replacements
  • good systemic health
  • smoking less than 10 cig/day

Exclusion criteria

  • periodontal treatment lass than 1 year before inclusion
  • antibiotic therapy in the last 6 months
  • chronic systemic diseases with the impact on periodontium or healing process
  • medication with the impact on periodontium or healing process

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups, including a placebo group

ProlacSan
Experimental group
Description:
Patient will get ProlacSan lozenges after nonsurgical treatment of periodontitis.
Treatment:
Dietary Supplement: Probiotic lozenges
Placebo
Placebo Comparator group
Description:
Patients will get placebo lozenges after nonsurgical periodontal treatment
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems